Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
recursion
Overview
Recursion Pharmaceuticals is a leading clinical-stage biotechnology company at the forefront of tech-enabled drug discovery. They utilize a proprietary, high-content screening platform powered by artificial intelligence and machine learning to generate and analyze vast datasets of biological and chemical interactions. This data-driven approach allows them to identify promising drug candidates across multiple therapeutic areas, including rare diseases, oncology, and infectious diseases. By partnering with pharmaceutical giants and focusing on computationally intensive, data-rich biological insights, Recursion aims to revolutionize the drug development process, accelerating the identification of novel therapies and reducing the time and cost associated with bringing new drugs to market. Their market position is as a pioneer and innovator in the AI-driven drug discovery space, poised to disrupt traditional pharmaceutical R&D.
recursion's headcount breakdown by department
| Department | HeadCount |
|---|---|
Administrative | 20 |
Consulting | 2 |
Service | 2 |
Design | 9 |
Education | 0 |
Recursion Pharmaceuticals' department distribution strongly reflects its commitment to AI-driven drug discovery and technological innovation. The significant investment in 'Research' (183 employees) and 'Technical' (149 employees) teams, alongside a substantial 'Other Department' contingent (167 employees), likely composed of data scientists, bioinformaticians, and software engineers, underscores their core competency in data generation, analysis, and algorithm development. The presence of teams dedicated to 'Medical' (14 employees), 'Product' (16 employees), and 'Operations' (29 employees) suggests that Recursion is progressing beyond basic research towards clinical trials and product development, indicating a transition from purely discovery to more mature stages of pharmaceutical development. The relatively smaller 'Sales' (13 employees) and 'Marketing' (4 employees) teams suggest a current emphasis on research, development, and strategic partnerships over immediate commercial sales, which is typical for a biotech firm heavily reliant on licensing agreements and collaborative development programs. The 'General Management' (22 employees), 'Finance' (20 employees), 'HR' (18 employees), 'Legal' (7 employees), and 'Administrative' (20 employees) teams reflect the necessary support structure for a company of its size and strategic focus. Overall, the workforce structure is heavily weighted towards technology and R&D, confirming that Recursion Pharmaceuticals is a tech-heavy biotech firm that prioritizes innovation and scientific advancement.
recursion's employees by locations
Employee Count by Country
Total: 677 employees
Recursion Pharmaceuticals exhibits a multinational presence with a strategic concentration in North America and Europe, aligning with its business model of accessing diverse talent pools, collaborative research opportunities, and key regulatory environments. The United States, with 396 employees, serves as the company's primary operational and strategic hub, likely housing its headquarters and core R&D functions. A significant footprint in the United Kingdom (203 employees) and Canada (65 employees) suggests partnerships with academic institutions, access to a skilled workforce, and potential clinical trial activities within these regions. The smaller employee counts distributed across various European countries such as Austria, Netherlands, France, Spain, Sweden, Switzerland, and Poland indicate specialized functions, collaborative research ventures, or localized market development initiatives. This geographic distribution supports Recursion's strategy of leveraging global expertise in artificial intelligence, drug discovery, and clinical development to accelerate the identification and commercialization of novel therapeutics. While having international operations, their workforce data demonstrates a strong focus in the United States reflecting a domestic business strategy with global collaborations to foster expansion and reach broader talent and clinical trial opportunities.
Want to stay ahead of recursion's org changes?
Get alerts when hiring spikes or teams shift focus
Track changes vs. competitors
Spot warm GTM signals early